Ghana votes as candidates pitch route out of economic crisis
By Christian Akorlie ACCRA (Reuters) - Ghanaians vote in elections on Monday in which President Nana Akufo-Addo and former president John Mahama offer rival promises to help the economy rebound from its first quarterly contraction in nearly 40 years. Eyes are on the West African economic powerhouse to see if it can maintain its standing as a bastion of democracy in the unstable region where election disputes this year have fanned fears of a slide back into authoritarianism.
By Christian Akorlie
ACCRA (Reuters) - Ghanaians vote in elections on Monday in which President Nana Akufo-Addo and former president John Mahama offer rival promises to help the economy rebound from its first quarterly contraction in nearly 40 years.
Eyes are on the West African economic powerhouse to see if it can maintain its standing as a bastion of democracy in the unstable region where election disputes this year have fanned fears of a slide back into authoritarianism.
There are 12 presidential candidates, but most voters are likely to choose between Akufo-Addo and his New Patriotic Party, and Mahama's National Democratic Congress, which have alternated in power since 1992.
Last year Ghana emerged from a three-year lending programme with the International Monetary Fund only for the new coronavirus to knock demand for its key exports of oil and cocoa.
If re-elected for a second four-year term, Akufo-Addo promises to push ahead with a $17 billion recovery programme to boost jobs, while Mahama's keystone pledge is a $10 billion infrastructure plan.
The race is expected to be tight, though commentators say Akufo-Addo has a slight lead based on his performance during the pandemic in which his administration provided free water and subsidised electricity to households.
"He has brought hope to many Ghanaians through his social interventions. It's been a difficult year," said 45-year-old businesswoman Evelyn Amey in the capital Accra.
The two sides agreed on Friday to resolve any electoral disputes in court, after fears that unofficial security groups hired by politicians could disrupt the vote.
Polls open at 7 a.m. (0700 GMT) and close at 5 p.m. Results are expected no later than Dec. 10, but will likely come sooner.
(Writing by Alessandra Prentice; Editing by Edward McAllister and Raissa Kasolowsky)
This story has not been edited by Firstpost staff and is generated by auto-feed.
Find latest and upcoming tech gadgets online on Tech2 Gadgets. Get technology news, gadgets reviews & ratings. Popular gadgets including laptop, tablet and mobile specifications, features, prices, comparison.
BEIJING/GENEVA (Reuters) - A World Health Organization (WHO) team of international experts tasked with investigating the origins of the COVID-19 pandemic will arrive in China on Jan. 14, Chinese authorities said on Monday. Lack of authorisation from Beijing had delayed the arrival of the 10-strong team on a long-awaited mission to investigate early infections, in what China's foreign ministry called a "misunderstanding"
By Cristina Sanchez and Belén Carreño MADRID (Reuters) - Schools in Madrid remained shut, some supermarkets ran out of fresh produce and few cars were on the streets on Monday as officials urged people to stay home after a huge snow storm hit the Spanish capital and several regions over the weekend. However, most flights and trains, including the high-speed link to Barcelona, have resumed operations. While many people enjoyed the rare snowfall by skiing in the centre of Madrid and holding mass snowball fights, a further cold spell was set to turn the snow into ice this week and authorities rushed to clear more streets.
By Ludwig Burger FRANKFURT (Reuters) - Pfizer Inc's partner BioNTech SE has boosted the 2021 delivery target for their COVID-19 vaccine to 2 billion doses, up from 1.3 billion previously, as they add new production lines and as more doses can be extracted per vial. Special syringes known as low dead space syringes allow for extraction of six vaccine doses from a standard vial, instead of the usual five, avoiding wasting unused liquid left in a syringe. That would result in 1 billion people getting the designated two-dose regimen, BioNTech said on Monday in a presentation for the annual JP Morgan healthcare conference being held virtually this year due to the coronavirus pandemic.